NEC OncoImmunity AS Alternatives & Competitors
12 companies similar to NEC OncoImmunity AS — Empowering cancer immunotherapy with artificial intelligence
Companies similar to NEC OncoImmunity AS
Achilles Therapeutics plc
Personalised T cell therapies targeting clonal neoantigens
United Kingdom
Valo Therapeutics Ltd
Reinventing Cancer Immunotherapy
Helsinki, Finland
Odimma Therapeutics
Empowering Personalized Immunotherapy to Treat Cancer
France
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Emeryville, United States
Track all NEC OncoImmunity AS competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
BriaCell Therapeutics Corp.
Developing Novel Therapies to Destroy Cancer
Philadelphia, United Stat...
Neon Therapeutics
We turn cancer’s most daunting weapon into its biggest vulnerability.
Cambridge, United States
-logo.jpg "VBL Therapeutics (Nasdaq:VBLT)"){kind=logo}
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Israel
ACT Genomics
Make Personalized Medicine Accessible To All.
Taiwan
TREOS THERAPEUTICS
Changing the paradigm of active cancer immunotherapy development
London, United Kingdom
Aster Insights
Accelerating oncology medical product discovery and development through our scientific and...
Tampa, United States
Treeline
Making medicines at the highest level
Watertown, United States
About NEC OncoImmunity AS
NEC OncoImmunity AS is a biotech company leveraging artificial intelligence (AI) to revolutionize cancer immunotherapy. The company specializes in proprietary machine-learning software that effectively predicts immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. With a diverse te...
Development of AI-driven personalized cancer vaccines and infectious disease vaccines using advanced predictive technologies
Patients in need of personalized cancer immunotherapy, individuals susceptible to infectious diseases, public-private consortiums focused on precision medicine implementation
Biotech, Cancer Immunotherapy, Infectious Disease Vaccines, Bioinformatics, Computational Immunology, Clinical Development, Personalized Medicine, Bioinformaticians, Immunologists, Cancer Research, Cell Therapies
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches NEC OncoImmunity AS and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at NEC OncoImmunity AS on 25 Mar 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
